Search EMBC
Embecta Corp.
Nasdaq · CIK 1872789
Last close5.65
Daily change-0.14 (-2.42%)
10 Years gain-83.15%
Dividends TTM0.32 (-46.67%)
Dividend yield5.53%
Fundamental Analysis
EMBC · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0930
Fundamental
44.6Momentum
87.9Acceleration
84.4Confidence
100.0Annual Revenue6
Quarterly Revenue21
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth9.5 / 25
Quality11.2 / 25
Capital Efficiency8.0 / 20
Balance Sheet5.6 / 15
Shareholder Economics8.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 7.575 percentage points.
FCF growthFree cash flow grew 396.1765%.
ROIC expansionROIC improved by 5.8515 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.0598%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 3.5422 percentage points.
Key Metrics
Revenue Growth TTM-2.81%OK
Revenue CAGR 3Y-1.47%OK
Gross Margin60.93%OK
Operating Margin24.85%OK
FCF Margin16.06%OK
FCF Growth396.18%OK
ROIC28.26%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO7.24xOK
Diluted Share Growth 1Y-0.06%OK
SBC / Revenue2.07%OK
SBC / FCF12.86%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $1.08B | $676.80M | $242.10M | $191.70M | $182.40M | 62.64% | 22.41% | 16.88% | 31.06% | 58.92M |
| 2025 FY Sep 30, 2024 | $1.12B | $735.20M | $166.80M | $35.70M | $19.90M | 65.46% | 14.85% | 1.77% | 21.17% | 58.33M |
| 2025 FY Sep 30, 2023 | $1.12B | $749.90M | $221.50M | $67.70M | $41.20M | 66.91% | 19.76% | 3.68% | 35.1% | 57.76M |
| 2024 FY Sep 30, 2022 | $1.13B | $774.90M | $309.60M | $412.20M | $388.60M | 68.61% | 27.41% | 34.4% | 55.08% | 57.46M |
| 2023 FY Sep 30, 2021 | $1.17B | $800.40M | $492.00M | $456.30M | $419.50M | 68.69% | 42.22% | 36% | 70.7% | 57.01M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.05B | sum latest 4 fiscal quarters Revenue | OK | 0001872789-26-000033, 0001872789-26-000009 |
| Revenue Growth TTM | -2.81% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001872789-26-000033, 0001872789-26-000009 |
| Revenue CAGR 3Y | -1.47% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001872789-25-000036 |
| Revenue CAGR 5Y | -0.09% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001872789-25-000036 |
| Gross Profit CAGR 3Y | -4.41% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001872789-25-000036 |
| Operating Income Growth | 39.8% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001872789-26-000033, 0001872789-26-000009 |
| FCF Growth | 396.18% | FCF_current / FCF_prior_year - 1 | OK | 0001872789-26-000033, 0001872789-26-000017 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 60.93% | Gross Profit / Revenue | OK | 0001872789-26-000033, 0001872789-26-000009 |
| Operating Margin | 24.85% | Operating Income / Revenue | OK | 0001872789-26-000033, 0001872789-26-000009 |
| FCF Margin | 16.06% | (CFO - CapEx) / Revenue | OK | 0001872789-26-000033, 0001872789-26-000017 |
| CFO / Net Income | 1.61x | CFO / Net Income | OK | 0001872789-26-000033, 0001872789-26-000017 |
| FCF / Net Income | 1.58x | FCF / Net Income | OK | 0001872789-26-000033, 0001872789-26-000017 |
| ROIC | 28.26% | NOPAT / Average Invested Capital | OK | 0001872789-26-000033, 0001872789-26-000009 |
| Net Debt / CFO | 7.24x | Net Debt / CFO | OK | 0001872789-26-000033, 0001872789-26-000017 |